Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daily fractionated oral iron in adults with iron deficiency anemia
ChiCTR2200062595Phase 4Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferrous succinate in iron deficiency anemia (IDA) (3 arms), sponsored by Huashan Hospital. Primary endpoint: Hemoglobin. Planned start Sep 2022; status: not yet recruiting.
02
Drugs
ferrous succinate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ChiCTR2200062595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062595.